This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 116/19/2182    most recent CIRCULATIONAHA.107.698852v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thorp, E. Articles by Tabas, I. Search for Related Content PubMed PubMed Citation Articles by Thorp, E. Articles by Tabas, I. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Related Collections Animal models of human disease Apoptosis Pathophysiology Cell signalling/signal transduction Genetically altered mice

(Circulation. 2007;116:2182-2190.)
© 2007 American Heart Association, Inc.

Vascular Medicine

Pioglitazone Increases Macrophage Apoptosis and Plaque Necrosis in Advanced Atherosclerotic Lesions of Nondiabetic Low-Density Lipoprotein Receptor–Null Mice

Edward Thorp, PhD; George Kuriakose, MSc; Yatrik M. Shah, PhD; Frank J. Gonzalez, PhD; Ira Tabas, MD, PhD

From the Departments of Medicine, Pathology and Cell Biology, and Physiology and Cellular Biophysics, Columbia University, New York, NY (E.T., G.K., I.T.), and the Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md (Y.M.S., F.J.G.).

Correspondence to Ira Tabas, MD, PhD, Department of Medicine, Columbia University, 630 W 168th St, New York, NY 10032. E-mail iat1{at}columbia.edu

Received February 24, 2007; accepted September 7, 2007.

Background— Thiazolidinediones (TZDs), which have actions that involve both peroxisome proliferator–activated receptor (PPAR)-–dependent and –independent effects, improve insulin sensitivity in type II diabetes and inhibit early atherogenesis in mice. However, the effects of TZDs on advanced lesion progression are unknown.

Methods and Results— Pioglitazone and rosiglitazone enhanced macrophage apoptosis by a number of stimuli, including those thought to be important in advanced atherosclerosis. Macrophage death was not enhanced by non-TZD PPAR activators, and TZD-induced apoptosis was still observed in PPAR-deficient macrophages. In wild-type macrophages, death enhancement was associated with reduced activation of the cell-survival mediator nuclear factor-B. TZDs also increased the ability of macrophages to phagocytically clear apoptotic cells, which is proposed to protect against plaque necrosis in advanced lesions. The mechanism of this effect was complex, involving both PPAR-dependent and -independent mechanisms. To explore the net effect on advanced atherosclerosis in vivo, Ldlr^–/– mice were fed a nondiabetogenic cholesterol-enriched diet to promote midstage lesions. Then, pioglitazone was administered with the diet for an additional 10 weeks. Aortic root lesions from the pioglitazone-treated mice showed a substantial increase in apoptotic cells and plaque necrosis compared with lesions from non–drug-treated mice.

Conclusions— The potential atheroprotective effects of TZDs conferred by insulin sensitization may be partially offset by adverse effects on advanced atherosclerosis. Because the mechanisms of the beneficial and proposed adverse effects may differ, these findings have potentially important implications for drug optimization.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				E. Thorp and I. Tabas Differential Effects of Pioglitazone on Advanced Atherosclerotic Lesions Am. J. Pathol., September 1, 2009; 175(3): 1348 - 1348. [Abstract] [Full Text] [PDF]

				T. Seimon and I. Tabas Mechanisms and consequences of macrophage apoptosis in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S382 - S387. [Abstract] [Full Text] [PDF]

				T. Senokuchi, C.-P. Liang, T. A. Seimon, S. Han, M. Matsumoto, A. S. Banks, J.-H. Paik, R. A. DePinho, D. Accili, I. Tabas, et al. Forkhead Transcription Factors (FoxOs) Promote Apoptosis of Insulin-Resistant Macrophages During Cholesterol-Induced Endoplasmic Reticulum Stress Diabetes, November 1, 2008; 57(11): 2967 - 2976. [Abstract] [Full Text] [PDF]